Successful Direct Current Cardioversion (DCCV) in Pregnancy in a Non-Obstetric Emergency Department

Atrial Fibrillation (AF) is uncommon in pregnancy but associated with significant mortality. Although controlled studies evaluating therapeutic management of AF in pregnancy are lacking, current guidelines suggest that direct current cardioversion (DCCV) is safe in cases of maternal arrhythmia with hemodynamic compromise. In this report, we discuss a female patient of 22 weeks gestation who presented to the non-obstetric Emergency Department (ED) with acute onset, symptomatic AF. Following consultation with emergency medicine, cardiology, and maternal-fetal medicine specialists, rhythm control was favored for immediate management. A single 200 joules synchronized shock resulted in a successful reversion to sinus rhythm with no adverse events using agreed procedural sedation protocols. The patient had an uneventful inpatient course and was later discharged with outpatient cardiology and obstetric follow-up. This case contributes to the evidence that DCCV is safe in pregnant patients and proposes that standard medications used for analgesia and sedation in cardioversion are safe in pregnancy. A multidisciplinary team approach is key in managing AF in pregnancy in the acute non-obstetric setting.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2024-11-11
DOI
https://doi.org/10.7759/cureus.73419
Citations
2
Primary Topic
Cardiovascular Issues in Pregnancy
Type
article
Field-Weighted Citation Impact
0.80
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Successful Direct Current Cardioversion (DCCV) in Pregnancy in a Non-Obstetric Emergency Department

Eamonn Murphy, Bibi Ayesha Bassa, Cian McDermott, Leah Flanagan et al.
2 citations
Cureus
Cardiovascular Issues in Pregnancy
0.80
article

Successful Direct Current Cardioversion (DCCV) in Pregnancy in a Non-Obstetric Emergency Department

Eamonn Murphy, Bibi Ayesha Bassa, Cian McDermott, Leah Flanagan, Haleeda Hilmi
article en
2 citations

Abstract

Atrial Fibrillation (AF) is uncommon in pregnancy but associated with significant mortality. Although controlled studies evaluating therapeutic management of AF in pregnancy are lacking, current guidelines suggest that direct current cardioversion (DCCV) is safe in cases of maternal arrhythmia with hemodynamic compromise. In this report, we discuss a female patient of 22 weeks gestation who presented to the non-obstetric Emergency Department (ED) with acute onset, symptomatic AF. Following consultation with emergency medicine, cardiology, and maternal-fetal medicine specialists, rhythm control was favored for immediate management. A single 200 joules synchronized shock resulted in a successful reversion to sinus rhythm with no adverse events using agreed procedural sedation protocols. The patient had an uneventful inpatient course and was later discharged with outpatient cardiology and obstetric follow-up. This case contributes to the evidence that DCCV is safe in pregnant patients and proposes that standard medications used for analgesia and sedation in cardioversion are safe in pregnancy. A multidisciplinary team approach is key in managing AF in pregnancy in the acute non-obstetric setting.

CureusVol. 16(11)
Mater Misericordiae University Hospital (IE)
Good health and well-being
Openalex Percentile: Top 23%
Cardiovascular Issues in Pregnancy
0.80
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Successful Direct Current Cardioversion (DCCV) in Pregnancy in a Non-Obstetric Emergency Department — Eamonn Murphy, Bibi Ayesha Bassa, et al. · Cureus (2024) | TGRS Research Map | TGRS